Mr. Speaker, it is the government's intention to set regulatory requirements that would standardize the amount of tetrahydrocannabinol, THC, in certain cannabis products and to indicate the amounts of THC on product labels. In this way, consumers will have clear information upon which to make decisions about consumption and the risks they are taking.
Currently, under the access to cannabis for medical purposes regulations, ACMPR, the maximum allowable limit of THC in cannabis oil is 30 milligrams per milliliter. As well, for capsules of cannabis oil, in dosage form, the ACMPR limits the amount of THC per capsule to 10 mg. Health Canada is currently evaluating whether these limits will remain the same in the forthcoming regulations under the proposed cannabis act.